MedinCell S.A.
MDCLF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $13,621 | $16,106 | $9,435 | $3,765 |
| % Growth | -15.4% | 70.7% | 150.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $329 |
| Gross Profit | $0 | $16,106 | $9,435 | $3,436 |
| % Margin | 0% | 100% | 100% | 91.3% |
| R&D Expenses | $14,700 | $14,041 | $10,277 | $9,920 |
| G&A Expenses | $0 | $5,887 | $5,030 | $4,567 |
| SG&A Expenses | $8,547 | $7,460 | $6,716 | $5,797 |
| Sales & Mktg Exp. | $0 | $1,573 | $1,686 | $1,230 |
| Other Operating Expenses | $0 | -$2,084 | -$29 | $44 |
| Operating Expenses | $23,247 | $19,417 | $16,964 | $15,761 |
| Operating Income | -$10,736 | -$3,311 | -$7,529 | -$11,996 |
| % Margin | -78.8% | -20.6% | -79.8% | -318.6% |
| Other Income/Exp. Net | -$11,073 | -$528 | -$6,910 | -$4,796 |
| Pre-Tax Income | -$21,808 | -$3,839 | -$14,439 | -$16,792 |
| Tax Expense | -$2,942 | $31 | $129 | $88 |
| Net Income | -$18,867 | -$3,870 | -$14,568 | -$16,880 |
| % Margin | -138.5% | -24% | -154.4% | -448.3% |
| EPS | -0.57 | -0.13 | -0.5 | -0.58 |
| % Growth | -338.5% | 74% | 13.8% | – |
| EPS Diluted | -0.57 | -0.13 | -0.5 | -0.58 |
| Weighted Avg Shares Out | 33,084 | 31,835 | 29,101 | 28,891 |
| Weighted Avg Shares Out Dil | 33,084 | 31,835 | 29,101 | 28,974 |
| Supplemental Information | – | – | – | – |
| Interest Income | $943 | $711 | $0 | $794 |
| Interest Expense | $3,335 | $2,777 | $1,774 | $4,438 |
| Depreciation & Amortization | $1,110 | $1,651 | $339 | $432 |
| EBITDA | -$17,363 | -$3,941 | -$7,259 | -$11,551 |
| % Margin | -127.5% | -24.5% | -76.9% | -306.8% |